IM Cannabis (IMCC) Total Liabilities (2019 - 2026)
IM Cannabis (IMCC) posted quarterly Total Liabilities of $21.0 million for Q1 2026, down 27.78% year-over-year from $29.1 million in Q1 2025, and down 17.08% quarter-over-quarter from $25.3 million in Q4 2025.
IM Cannabis (IMCC) Total Liabilities (2019 - 2026) Analysis & Trends
IM Cannabis' Total Liabilities history runs 8 years deep, the most recent figure standing at $21.0 million for Q1 2026.
- In Q1 2026, Total Liabilities fell 27.78% year-over-year to $21.0 million; the TTM figure through Mar 2026 stood at $21.0 million (down 27.78% YoY), while the FY2025 annual figure was $25.3 million, down 3.7% from the prior year.
- Total Liabilities for Q1 2026 stood at $21.0 million, down from $25.3 million in the prior quarter.
- The five-year high for Total Liabilities was $65.3 million in Q1 2022, with the low at $21.0 million in Q1 2026.
- The 5-year median for Total Liabilities is $25.8 million (2024), against an average of $32.0 million.
- The sharpest annual moves came in 2022 and 2024: Total Liabilities tumbled 63.48% in 2022, then increased 21.97% in 2024.
- IM Cannabis' Total Liabilities stood at $27.2 million in 2022, then retreated by 5.07% to $25.8 million in 2023, then rose by 0.03% to $25.8 million in 2024, then dropped by 1.75% to $25.3 million in 2025, then declined by 17.08% to $21.0 million in 2026.
- Business Quant data shows IMCC's Total Liabilities at $21.0 million in Q1 2026, $25.3 million in Q4 2025, and $29.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.12 Bn |
| 10 | IM Cannabis | 554,496.00 | -614,474.17 | 1.09 Mn | 21.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.92 Mn |
| Mar 31, 2026 | 21.02 Mn |
| Dec 31, 2025 | 25.35 Mn |
| Sep 30, 2025 | 29.09 Mn |
| Jun 30, 2025 | 26.71 Mn |
| Mar 31, 2025 | 29.10 Mn |
| Dec 31, 2024 | 25.80 Mn |
| Sep 30, 2024 | 29.63 Mn |
| Jun 30, 2024 | 25.40 Mn |
| Mar 31, 2024 | 24.32 Mn |
| Dec 31, 2023 | 25.79 Mn |
| Sep 30, 2023 | 24.30 Mn |
| Jun 30, 2023 | 25.47 Mn |
| Mar 31, 2023 | 23.85 Mn |
| Dec 31, 2022 | 27.17 Mn |
| Sep 30, 2022 | 56.04 Mn |
| Jun 30, 2022 | 59.42 Mn |
| Mar 31, 2022 | 65.30 Mn |
| Dec 31, 2021 | 37.41 Mn |
| Jun 30, 2021 | 162.73 Mn |